IL12RB1 and graft versus host disease: Specifically, neither transfer of B6 donor cells deficient in either IL-12R or Ifnar1, nor combined antibody-mediated blockade of both cytokines altered the acute GVHD phenotype at two weeks (manuscript in preparation).